CRIS
Overvalued by 200.9% based on the discounted cash flow analysis.
Market cap | $25.21 Million |
---|---|
Enterprise Value | $8.17 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-6.88 |
Beta | 3.51 |
Outstanding Shares | 7,671,226 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.43 |
---|---|
PEG | 2.48 |
Price to Sales | 2.1 |
Price to Book Ratio | -2.1 |
Enterprise Value to Revenue | 0.8 |
Enterprise Value to EBIT | -0.17 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0.36 |
Debt to Equity | -0.49 |
No data
No data